Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Figure 1 Overview of the pathogenesis of chronic hepatitis C and how it contributes to atherosclerosis and cardiomyopathy.
HCV: Hepatitis C virus; TNF-α: Tumor necrosis factor-alpha; IL: Interleukin-6.
- Citation: Elkhattib I, Raafat KW, Elsayed B, Elnaggar M. Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. World J Hepatol 2025; 17(8): 108678
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108678.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108678